Results 41 to 50 of about 244,635 (318)

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

Blood Cancer Journal, 2020
CD19-targeted chimeric antigen receptor (CAR) T cell therapy is an effective treatment for diffuse large B cell lymphoma (DLBCL). In addition to cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity (ICANS), B cell aplasia and
K. Wudhikarn, M. Palomba, M. Pennisi, M. García‐Recio, Jessica R. Flynn, S. Devlin, A. Afuye, M. Silverberg, M. Maloy, G. Shah, M. Scordo, P. Dahi, C. Sauter, C. Batlevi, B. Santomasso, E. Mead, Susan K. Seo, M. Perales   +17 more
semanticscholar   +1 more source

Primary central nervous system CD20-negative diffuse large B-cell lymphoma: a case report

BMC Neurology, 2022
Background CD20-negative diffuse large B-cell lymphoma is a very rare and heterogeneous invasive cancer characterized by chemical resistance and poor prognosis.
Shuai Luo, Xiang Huang, Yao Li, Jinjing Wang   +3 more
doaj   +1 more source

Mantle cell lymphoma of the larynx: Primary case report [PDF]

, 2012
INTRODUCTION: Primary laryngeal lymphomas are exceedingly rare. Only about a hundred cases have been reported. They consist mainly of non-Hodgkin lymphoma, especially of diffuse large B-cell lymphoma and mucosa-associated lymphoid tissue.
Anass A Bennani-Baiti, Hassan Errihani, Houda Mouzount, Leila Essakali, Meriem Glaoui, Mohamed Kzadri, Samia Ghanem, Sarah Naciri   +7 more
core   +2 more sources

Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin’s lymphoma and primary mediastinal large B-cell lymphoma

Haematologica, 2011
Background Mediastinal gray zone lymphoma is a newly recognized entity with transitional morphological and immunophenotypic features between the nodular sclerosis subtype of Hodgkin’s lymphoma and primary mediastinal large B-cell lymphoma.
Franziska C. Eberle, Jaime Rodriguez-Canales, Lai Wei, Jeffrey C. Hanson, J. Keith Killian, Hong-Wei Sun, Lisa G. Adams, Stephen M. Hewitt, Wyndham H. Wilson, Stefania Pittaluga, Paul S. Meltzer, Louis M. Staudt, Michael R. Emmert-Buck, Elaine S. Jaffe   +13 more
doaj   +1 more source

Spinal cord compression by B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a patient seropositive for human immunodeficiency virus: a case report [PDF]

, 2014
INTRODUCTION: Although non-Hodgkin’s lymphoma is one of the most common and frequently fatal of the acquired immune deficiency syndrome-defining illnesses, survival has improved significantly since the introduction of antiretroviral therapy.
Jun-Yeong Seo, Kee-Yong Ha, Min-Up Kim, Yoon-Chung Kim, Young-Hoon Kim   +4 more
core   +1 more source

Transplant in Diffuse Large B-Cell Lymphoma

Brazilian Journal of Transplantation, 2022
Diffuse large B-cell lymphoma is the most common type of aggressive lymphoma. Patients that don’t respond to first-line therapy have a poor prognosis.
Guilherme Duffles, Carmino De Souza
doaj   +3 more sources

Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas

Haematologica, 2008
Background Follicular lymphomas are currently subdivided into grades I, II, IIIa and IIIb. This distinction is, however, questioned.Design and Methods We studied the gene expression profile of 43 follicular lymphomas, 50 B-cell non-Hodgkin’s lymphomas of
Pier Paolo Piccaluga, Andrea Califano, Ulf Klein, Claudio Agostinelli, Beatriz Bellosillo, Eva Gimeno, Sergi Serrano, Francisco Solè, Yonghui Zang, Brunangelo Falini, Pier Luigi Zinzani, Stefano A. Pileri   +11 more
doaj   +1 more source

Concurrent myasthenia gravis-related cervical thymoma in a patient with diffuse large B-cell lymphoma: a case report

Journal of Medical Case Reports, 2022
Background Cervical thymoma is a rare thymic epithelial neoplasm. Evidence supports an increased risk of second primary malignancies in patients with thymoma.
Chutima Kunacheewa, Sattawut Wongwiangjunt, Sanya Sukpanichnant   +2 more
doaj   +1 more source

Post-CAR-T cell therapy presenting as proteinaceous lymphadenopathy

Human Pathology: Case Reports, 2021
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and is often treated with chemotherapy, autologous stem cell transplant, and chimeric antigen receptor (CAR-T) cell therapy.
Mishi Bhushan, Kirthi R. Kumar
doaj   +1 more source

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology, 2019
PURPOSE Patients with transplantation-ineligible relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) fare poorly, with limited treatment options.
L. Sehn, A. Herrera, C. Flowers, M. Kamdar, A. McMillan, M. Hertzberg, S. Assouline, T. Kim, W. Kim, M. Ozcan, J. Hirata, E. Penuel, J. Paulson, Ji Cheng, G. Ku, M. Matasar   +15 more
semanticscholar   +1 more source